175 related articles for article (PubMed ID: 38019226)
1. Association of Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1 Alpha Coding Variants with Hepatocellular Carcinoma Risk in the Moroccan Population: A Case-Control Study.
Tanouti IA; Fellah H; El Fihry R; Zerrad C; Abounouh K; Tahiri M; Belkouchi A; Badre W; Pineau P; Benjelloun S; Ezzikouri S
Asian Pac J Cancer Prev; 2023 Nov; 24(11):3689-3696. PubMed ID: 38019226
[TBL] [Abstract][Full Text] [Related]
2. Effect of Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Alpha Variants on Spontaneous Clearance and Fibrosis Progression during Hepatitis C Virus Infection in Moroccan Patients.
ElFihry R; Elmessaoudi-Idrissi M; Jadid FZ; Zaidane I; Chihab H; Tahiri M; Kabine M; Badre W; Chemin I; Marchio A; Pineau P; Ezzikouri S; Benjelloun S
Virol Sin; 2020 Oct; 35(5):566-574. PubMed ID: 32297157
[TBL] [Abstract][Full Text] [Related]
3. The peroxisome proliferator-activated receptor γ coactivator-1 alpha rs8192678 (Gly482Ser) variant and hepatitis B virus clearance.
Abounouh K; Tanouti IA; Ouladlahsen A; Tahiri M; Badre W; Dehbi H; Sarih M; Benjelloun S; Pineau P; Ezzikouri S
Infect Dis (Lond); 2023 Sep; 55(9):614-624. PubMed ID: 37376899
[TBL] [Abstract][Full Text] [Related]
4. A common variant in the peroxisome proliferator-activated receptor-γ coactivator-1α gene is associated with nonalcoholic fatty liver disease in obese children.
Lin YC; Chang PF; Chang MH; Ni YH
Am J Clin Nutr; 2013 Feb; 97(2):326-31. PubMed ID: 23269818
[TBL] [Abstract][Full Text] [Related]
5. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients.
Tai CM; Huang CK; Tu HP; Hwang JC; Yeh ML; Huang CF; Huang JF; Dai CY; Chuang WL; Yu ML
Medicine (Baltimore); 2016 Mar; 95(12):e3120. PubMed ID: 27015186
[TBL] [Abstract][Full Text] [Related]
6. PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease.
Zhang RN; Shen F; Pan Q; Cao HX; Chen GY; Fan JG
World J Gastroenterol; 2021 Jul; 27(25):3863-3876. PubMed ID: 34321850
[TBL] [Abstract][Full Text] [Related]
7. Assessment of
Chen Z; Wang Y; Wang J; Kang M; Tang W; Chen S
DNA Cell Biol; 2020 Sep; 39(9):1521-1531. PubMed ID: 32721231
[TBL] [Abstract][Full Text] [Related]
8. Association between PPARγ, PPARGC1A, and PPARGC1B genetic variants and susceptibility of gastric cancer in an Eastern Chinese population.
Chen B; Wang Y; Tang W; Chen Y; Liu C; Kang M; Xie J
BMC Med Genomics; 2022 Dec; 15(1):274. PubMed ID: 36587194
[TBL] [Abstract][Full Text] [Related]
9.
Yvert T; Miyamoto-Mikami E; Tobina T; Shiose K; Kakigi R; Tsuzuki T; Takaragawa M; Ichinoseki-Sekine N; Pérez M; Kobayashi H; Tanaka H; Naito H; Fuku N
Genes (Basel); 2020 Aug; 11(9):. PubMed ID: 32867330
[No Abstract] [Full Text] [Related]
10. Polymorphisms in the TFAM and PGC1-α genes and their association with polycystic ovary syndrome among South Indian women.
Reddy TV; Govatati S; Deenadayal M; Shivaji S; Bhanoori M
Gene; 2018 Jan; 641():129-136. PubMed ID: 29030253
[TBL] [Abstract][Full Text] [Related]
11. PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level.
Zhu L; Huang Q; Xie Z; Kang M; Ding H; Chen B; Chen Y; Liu C; Wang Y; Tang W
Oncotarget; 2017 Jun; 8(23):37308-37320. PubMed ID: 28418876
[TBL] [Abstract][Full Text] [Related]
12. Association between the PPARGC1A Gly482Ser polymorphism and muscle fitness in Chinese schoolchildren.
Wei Q
PLoS One; 2023; 18(4):e0284827. PubMed ID: 37104269
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.
Besse-Patin A; Léveillé M; Oropeza D; Nguyen BN; Prat A; Estall JL
Gastroenterology; 2017 Jan; 152(1):243-256. PubMed ID: 27658772
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
[TBL] [Abstract][Full Text] [Related]
15. Systematic Meta-analysis Revealed an Association of PGC-1
Xia W; Chen N; Peng W; Jia X; Yu Y; Wu X; Gao H
Dis Markers; 2019; 2019():2970401. PubMed ID: 30944665
[TBL] [Abstract][Full Text] [Related]
16. Engineered allele substitution at PPARGC1A rs8192678 alters human white adipocyte differentiation, lipogenesis, and PGC-1α content and turnover.
Huang M; Claussnitzer M; Saadat A; Coral DE; Kalamajski S; Franks PW
Diabetologia; 2023 Jul; 66(7):1289-1305. PubMed ID: 37171500
[TBL] [Abstract][Full Text] [Related]
17. Association and interaction analysis of PPARGC1A and serum uric acid on type 2 diabetes mellitus in Chinese Han population.
Wu HH; Liu NJ; Yang Z; Tao XM; Du YP; Wang XC; Lu B; Zhang ZY; Hu RM; Wen J
Diabetol Metab Syndr; 2014; 6(1):107. PubMed ID: 25302081
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis demonstrates Gly482Ser variant of PPARGC1A is associated with components of metabolic syndrome within Asian populations.
Bhatta P; Bermano G; Williams HC; Knott RM
Genomics; 2020 Mar; 112(2):1795-1803. PubMed ID: 31678594
[TBL] [Abstract][Full Text] [Related]
19. Correlation Between
Du F; Yang KJ; Piao LS
Open Life Sci; 2019 Jan; 14():43-52. PubMed ID: 33817136
[TBL] [Abstract][Full Text] [Related]
20. Association between
Zerrad C; Lkhider M; Belkouchi A; Tanouti IA; Badre W; Tahiri M; Ayassi S; Marchio A; Pineau P; Benjelloun S; Ezzikouri S
Nucleosides Nucleotides Nucleic Acids; 2023; 42(12):986-1003. PubMed ID: 37330637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
